Clinical trial Recruiting at 1 site Observational Ages 1 Month to 99

Investigation of Nontuberculous Mycobacteria Outbreaks in Healthcare Settings

Official title: Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)

Run by University of North Carolina, Chapel Hill · NCT06155747 · Data updated 2026-11-12

This study is trying to find out if nontuberculous mycobacteria infections in healthcare settings are spreading between patients and where they might be coming from.

More Mycobacterium Infections trials

Quick facts

Study typeObservational
Ages1 Month to 99 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity of North Carolina, Chapel Hill
Academic / other
Locations1 site (Chapel Hill, North Carolina)
StatusRecruiting
StartedMarch 1, 2023
Main results expectedDecember 28, 2036
Study endsDecember 28, 2036
Registry record updatedMay 26, 2026
Trial IDNCT06155747 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals of any age with a history of nontuberculous mycobacteria or a first positive NTM culture from clinical care.

Probably not a fit

Patients who do not have a respiratory culture indicating nontuberculous mycobacteria will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to standardize the investigation of nontuberculous mycobacteria (NTM) outbreaks in healthcare facilities. It will analyze respiratory NTM isolates from patients to determine if they are genetically related, indicating potential patient-to-patient transmission. The study will also assess environmental samples to identify sources of NTM acquisition. Participants will complete a demographic questionnaire to support the epidemiological investigation. The research utilizes whole genome sequencing to identify clusters of infections and adapt CDC guidelines for outbreak investigations.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of NTM transmission in healthcare settings, leading to improved infection control measures.

How similar studies have gone: Other studies have successfully utilized whole genome sequencing for outbreak investigations, suggesting this approach may yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female participant of any age who has a history of NTM or a first positive NTM culture collected as part of routine clinical care from expectorated sputum, induced sputum and/or bronchoalveolar lavage.

Exclusion Criteria:

* No NTM respiratory culture

Where it's running

  • University of North Carolina- Chapel Hill
    Chapel Hill, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Jane Gross, MD, PhD — University of North Carolina, Chapel Hill
  • Study coordinator: Principal Investigator
  • Email: Jane_gross@med.unc.edu
  • Phone: 919-445-4240

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Early treatment with targeted antibiotics for severe infections using rapid diagnostics

    This study is testing if giving targeted antibiotics right away, based on quick test results, can help hospitalized patients with severe infections caused by tough-to-treat bacteria feel better faster than standard care.

    Recruiting at 21 sites Phase 4 National University of Singapore · Vellore and 20 other locations · NCT05979545

  • Gene expression profiles in spinal tuberculosis

    This study is trying to see if different gene patterns in spinal tuberculosis can help doctors better understand and treat the disease, especially in people with HIV.

    Recruiting University of Cape Town · Cape Town, Western Cape · NCT05610098

  • Understanding the natural history of tuberculosis

    This study is trying to learn more about tuberculosis by collecting samples and monitoring treatment in people with active or latent TB to improve how we understand and treat the disease.

    Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT01212003

  • Examining Mycobacterial Infections

    This study is trying to learn more about non-tuberculous mycobacterial infections in people with certain health conditions to see how they affect symptoms and treatment options.

    Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT00018044

  • BCG vaccine to treat MAC lung disease

    This will test whether a single BCG vaccine injection can safely boost immunity and help adults with Mycobacterium avium complex (MAC) lung disease.

    Recruiting Phase 2 University of Virginia · Charlottesville, Virginia · NCT07094711

  • Rehabilitation and education for airway clearance in patients with NTM-PD

    This study is testing if an 8-week program of lung exercises and education can help adults with nontuberculous mycobacterial pulmonary disease breathe better and feel healthier.

    Recruiting at 2 sites Seoul National University Bundang Hospital · Seongnam-si, Gyeonggi-do and 1 other locations · NCT06838442

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.